Cerebrospinal fluid B-cell activating factor levels as a novel biomarker in patients with neurosarcoidosis

This study aims to investigate B-cell-activating factor of the tumor necrosis factor family (BAFF) in cerebrospinal fluid (CSF) and elucidate the relationship between CSF BAFF levels and various parameters of NS.
Source: Journal of the Neurological Sciences - Category: Neurology Authors: Tags: Clinical short communication Source Type: research
More News: Brain | Neurology | Sarcoidosis | Study